TAF I p63_TAF I p68 Inhibitors
TAF I p63_TAF I p68 inhibitors represent a class of chemical compounds designed to modulate the activity of transcription initiation factors involved in gene expression. These inhibitors specifically target the TAF I p63 and TAF I p68 proteins, which are integral components of the RNA polymerase II transcriptional machinery. TAF I p63 and TAF I p68, belonging to the TATA-binding protein-associated factor (TAF) family, play crucial roles in the assembly of the transcription preinitiation complex, facilitating the initiation of RNA synthesis. The inhibitors exert their effect by disrupting the interaction between these transcription factors and the DNA template, thus impeding the formation of the preinitiation complex and subsequently hindering the initiation of transcription.
TAF I p63_TAF I p68 inhibitors are designed with a focus on binding to specific regions on TAF I p63 and TAF I p68, preventing their proper interaction with DNA. This interference with the transcriptional machinery represents a novel approach to modulating gene expression, with potential implications for various biological processes. The development of these inhibitors stems from a detailed understanding of the molecular interactions involved in transcription initiation and a desire to selectively target and regulate these processes at the molecular level. Researchers are exploring the structural nuances and binding affinities of TAF I p63_TAF I p68 inhibitors to optimize their efficacy and selectivity, laying the groundwork for potential applications in unraveling the intricacies of gene regulation and expanding our knowledge of fundamental cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is a diterpene triepoxide that inhibits transcription by targeting the XPB subunit of TFIIH, which is necessary for transcription initiation. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB is an adenosine analog that interferes with the phosphorylation of the C-terminal domain of RNA polymerase II, thus affecting the initiation and elongation phases of transcription. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin is a cyclic peptide toxin from the Amanita phalloides mushroom, which inhibits RNA polymerase II, effectively blocking mRNA synthesis during transcription initiation. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases (CDKs), particularly CDK9 which is a component of P-TEFb involved in the transition from transcription initiation to elongation. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151 is a BET bromodomain inhibitor that disrupts the interaction between acetylated histones and BET family proteins, affecting the transcription regulation of certain genes. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a small molecule inhibitor of BET bromodomains, similar to I-BET151, which alters the expression of genes controlled by BET proteins, impacting transcription initiation. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
RGFP966 is an HDAC3 inhibitor, altering chromatin structure and affecting gene transcription possibly including those involving TAF1 subunits. | ||||||
THZ1 | 1604810-83-4 | sc-507542 | 1 mg | $95.00 | ||
THZ1 is a covalent inhibitor of CDK7, which is part of the transcription initiation complex, targeting its kinase activity and therefore affecting transcription initiation. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
CX-5461 selectively inhibits RNA polymerase I, indirectly reducing the demand on the transcription initiation machinery for RNA polymerase II where TAF1 subunits are involved. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Pladienolide B targets the SF3b complex of the spliceosome, which could indirectly influence transcription initiation by affecting pre-mRNA splicing. | ||||||